Cancer medication helps reduce SIV reservoir, increases hope for HIV cure | EurekAlert!
Venetoclax, an approved medication for cancer, is effective at reducing simian immunodeficiency virus reservoir levels in vivo when given in combination with antiretroviral therapy. This study offers hope for accelerating the timeline to cure by using an approved medication.